ArriVent Non Currrent Assets Other vs Short Term Debt Analysis
| AVBP Stock | 27.45 0.86 3.23% |
ArriVent BioPharma, financial indicator trend analysis is way more than just evaluating ArriVent BioPharma, prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether ArriVent BioPharma, is a good investment. Please check the relationship between ArriVent BioPharma, Non Currrent Assets Other and its Short Term Debt accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ArriVent BioPharma, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Non Currrent Assets Other vs Short Term Debt
Non Currrent Assets Other vs Short Term Debt Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of ArriVent BioPharma, Non Currrent Assets Other account and Short Term Debt. At this time, the significance of the direction appears to have almost identical trend.
The correlation between ArriVent BioPharma,'s Non Currrent Assets Other and Short Term Debt is 0.93. Overlapping area represents the amount of variation of Non Currrent Assets Other that can explain the historical movement of Short Term Debt in the same time period over historical financial statements of ArriVent BioPharma, Common, assuming nothing else is changed. The correlation between historical values of ArriVent BioPharma,'s Non Currrent Assets Other and Short Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Currrent Assets Other of ArriVent BioPharma, Common are associated (or correlated) with its Short Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Debt has no effect on the direction of Non Currrent Assets Other i.e., ArriVent BioPharma,'s Non Currrent Assets Other and Short Term Debt go up and down completely randomly.
Correlation Coefficient | 0.93 |
| Relationship Direction | Positive |
| Relationship Strength | Very Strong |
Non Currrent Assets Other
Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.Short Term Debt
Most indicators from ArriVent BioPharma,'s fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into ArriVent BioPharma, current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ArriVent BioPharma, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. As of 11/25/2024, Selling General Administrative is likely to drop to about 7 M. In addition to that, Issuance Of Capital Stock is likely to drop to about 38.4 M
ArriVent BioPharma, fundamental ratios Correlations
Click cells to compare fundamentals
ArriVent BioPharma, Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pair Trading with ArriVent BioPharma,
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ArriVent BioPharma, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ArriVent BioPharma, will appreciate offsetting losses from the drop in the long position's value.Moving against ArriVent Stock
| 0.71 | MTEM | Molecular Templates | PairCorr |
| 0.67 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.62 | TPST | Tempest Therapeutics | PairCorr |
| 0.6 | ME | 23Andme Holding | PairCorr |
| 0.57 | AGL | agilon health Buyout Trend | PairCorr |
The ability to find closely correlated positions to ArriVent BioPharma, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ArriVent BioPharma, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ArriVent BioPharma, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ArriVent BioPharma, Common to buy it.
The correlation of ArriVent BioPharma, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ArriVent BioPharma, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ArriVent BioPharma, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ArriVent BioPharma, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for ArriVent Stock Analysis
When running ArriVent BioPharma,'s price analysis, check to measure ArriVent BioPharma,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ArriVent BioPharma, is operating at the current time. Most of ArriVent BioPharma,'s value examination focuses on studying past and present price action to predict the probability of ArriVent BioPharma,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ArriVent BioPharma,'s price. Additionally, you may evaluate how the addition of ArriVent BioPharma, to your portfolios can decrease your overall portfolio volatility.